FDA Bans Certain Imports From Indian Drugmaker Wockhardt

Law360, New York (May 23, 2013, 4:04 PM EDT) -- The U.S. Food and Drug Administration on Wednesday blocked certain imports from India-based drugmaker Wockhardt Ltd. after inspections allegedly turned up violations of good manufacturing practices.

The so-called import alert affects medications that Wockhardt produces at a plant in the Indian city of Aurangabad, which sits about 200 miles east of Mumbai. Company executives predicted it will take months to have the ban lifted and that, in a worst-case scenario, they stand to lose $100 million in revenue, according to published reports.

Wockhardt has 14 manufacturing...
To view the full article, register now.